Home / Industry News / Details National Health Commission of the People's Republic of China Published 2018-08-23 Industry News 1 min read Share Copy link Click the link to access http://www.nhfpc.gov.cn/ ← Previous SZTT/SSCT 002-2018 'Specifications for Human Umbilical Cord-Derived Mesenchymal Stem Cell Preparations for Clinical Research' Next → State Administration for Market Regulation Related articles 2023-10-10 CDE issues Guiding Principles: organoids may serve as efficacy and safety evaluation models for non-clinical research of human-derived stem cell products 2021-12-06 Major News! Organoids Listed for the First Time in CDE Guidelines for Gene Therapy and Cell Therapy 2021-11-27 Shenzhen Issues "1+3" Documents on Cluster Development of the Biopharmaceutical Industry; Up to RMB 300 Million Funding for Key Cell-Drug Technology!
